Home/Filings/4/0000930413-10-005809
4//SEC Filing

HORAK IVAN D 4

Accession 0000930413-10-005809

CIK 0000727510other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 2:42 PM ET

Size

9.0 KB

Accession

0000930413-10-005809

Insider Transaction Report

Form 4
Period: 2010-11-23
HORAK IVAN D
EVP, R&D, Chief Scientific Off
Transactions
  • Exercise/Conversion

    Common Stock

    2010-11-23+3,000138,188 total
  • Tax Payment

    Common Stock

    2010-11-23$10.92/sh1,063$11,608137,125 total
  • Exercise/Conversion

    Restricted Stock Units

    2010-11-233,0000 total
    Exercise: $0.00From: 2010-11-23Exp: 2010-11-23Common Stock (3,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit was the economic equivalent of one share of the Issuer's common stock. The reporting person settled the vested restricted stock units for shares of the Issuer's common stock.
  • [F2]Shares were withheld from the Reporting Person, in an exempt transaction under Rule 16b-3, solely to satisfy tax obligations arising from the vesting of the restricted stock units described in this Form 4.

Documents

1 file

Issuer

ENZON PHARMACEUTICALS INC

CIK 0000727510

Entity typeother

Related Parties

1
  • filerCIK 0001247903

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 2:42 PM ET
Size
9.0 KB